[Event Report] The 29th Special Breakfast Meeting featuring Dr. Peter Piot on Local Responses to Global Health Issues
date : 6/5/2015
Tags: Other activities
Speaker: Dr. Peter Piot
Topic: Local Responses to Global Health Issues
Date: June 5, 2015
Venue: Roppongi Hills Club, Roppongi Hills Mori Tower
Co-organizer: Global Health Innovative Technology Fund (GHIT Fund)
Because global health is a critical component of health policy, Health and Global Policy Institute regularly hold global health related events. At this event, we welcomed Dr. Peter Piot, Director of the London School of Hygiene & Tropical Medicine and recipient of the Hideyo Noguchi Africa Prize, to speak at a Special Breakfast Meeting.
In addition to discovering the Ebola virus in 1976, Dr. Piot was the founding head of UNAIDS until 2008, during which time he played a key role in increasing making anti-retroviral therapy accessible in Africa by bringing prices down while balancing innovation. At this event, Dr. Piot discussed the changing face of global health and shared his ideas on the transformative leadership needed to build stronger health systems around the world and in Japan.
After the discussion, Dr. Piot took questions from the floor. Topics included communication with stakeholders when daring to diverge from usual course of action; measures and education needed to grow a strong base of global health capable people and organizations in Japan; and the reforms needed at the WHO given the increased focus on global governance.
Exhibition date:2015-06-05
Top Research & Recommendations Posts
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Report] 2017 Public Survey on Healthcare in Japan
- [Research Report] Public Opinion Survery on the Threat of Antimicrobial Resistance (AMR) (November 26, 2021)